Publications of Torsten Klengel
All genres
Journal Article (38)
2013
Journal Article
16 (1), pp. 33 - 41 (2013)
Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. NATURE NEUROSCIENCE
Journal Article
16 (1), pp. 33 - 41 (2013)
Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nature Neuroscience 2012
Journal Article
18 (36), pp. 5879 - 5889 (2012)
Epigenetics, Depression and Antidepressant Treatment. Current Pharmaceutical Design
Journal Article
37 (6), pp. 1455 - 1464 (2012)
Dexamethasone Stimulated Gene Expression in Peripheral Blood is a Sensitive Marker for Glucocorticoid Receptor Resistance in Depressed Patients. Neuropsychopharmacology
Journal Article
37 (3), pp. 797 - 807 (2012)
Genome-Wide Association Study of Antidepressant Treatment-Emergent Suicidal Ideation. Neuropsychopharmacology 2011
Journal Article
124 (4), pp. 317 - 328 (2011)
Somatization in major depression - clinical features and genetic associations. Acta Psychiatrica Scandinavica
Journal Article
44 (6), p. 295 - 295 (2011)
BDNF and NTRK2 polymorphisms and antidepressant treatment outcome. Pharmacopsychiatry
Journal Article
68 (9), pp. 901 - 910 (2011)
Using Polymorphisms in FKBP5 to Define Biologically Distinct Subtypes of Posttraumatic Stress Disorder Evidence From Endocrine and Gene Expression Studies. Archives of General Psychiatry
Journal Article
44 (6), p. 300 - 300 (2011)
Gender related differential response to dexamethasone in endocrine and immune measures in depressed patients and healthy controls. Pharmacopsychiatry
Journal Article
21 (Suppl. 3), pp. S248 - S249 (2011)
Glucocorticoid induced FKBP5-gene expression in depressed patients and healthy controls. European Neuropsychopharmacology
Journal Article
44 (6), p. 308 - 308 (2011)
Effectiveness of a standardized cognitive training in depression and the interaction with HPA-axis regulation. Pharmacopsychiatry
Journal Article
69 (9 Suppl.1), p. 152 S - 152 S (2011)
BDNF and NTRK2 Polymorphisms and Antidepressant Treatment Response. Biological Psychiatry
Journal Article
69 (9 Suppl.1), p. 153 S - 153 S (2011)
Glucocorticoid Induced FKBP5-gene Expression as a Biomarker for Depression? Biological Psychiatry
Journal Article
8 (1), pp. 23 - 34 (2011)
Using gene-environment interactions to target personalized treatment in mood disorder. Personalized Medicine 2010
Journal Article
20 (Suppl. 3), pp. S427 - S428 (2010)
Polymorphisms in the BDNF gene are associated with antidepressant treatment response. European Neuropsychopharmacology
Journal Article
67 (9 Suppl.1), pp. 127S - 128S (2010)
Polymorphisms in the BDNF Gene are Associated with Antidepressant Treatment Response. Biological Psychiatry
Journal Article
67 (9 Suppl.1), p. 129S - 129S (2010)
Genome-Wide Gene-Expression Profiles Following Glucocorticoid Stimulation Associated with Major Depression. Biological Psychiatry
Journal Article
20 (Suppl. 1), pp. S85 - S86 (2010)
Somatisation in major depression, genetic association and clinical features. European Neuropsychopharmacology Meeting Abstract (3)
2014
Meeting Abstract
75 (9), pp. 290S - 291S. 69th Annual Scientific Convention and Meeting of the
Society-of-Biological-Psychiatry, New York, NY. Elesvier Science Inc., New York, NY, USA (2014)
Modulation of FKBP5 Gene By Environment Interaction by a Structural Variant. In BIOLOGICAL PSYCHIATRY,
Meeting Abstract
75 (9), p. 45S - 45S. 69th Annual Scientific Convention and Meeting of the
Society-of-Biological-Psychiatry, New York, NY, May 08, 2014 - May 10, 2014. Elsevier Science Inc., New York, NY, USA (2014)
RNA Expression Profiling in Age-/Severity-Matched Depressed Inpatients Revealed New Candidates as Possible Biomarkers for Antidepressant Response. In BIOLOGICAL PSYCHIATRY,